OTCMKTS:TCNNF

Trulieve Cannabis - TCNNF Stock Forecast, Price & News

$6.75

+0.01 (+0.09%)

(As of 02/1/2023 12:00 AM ET)

Add

Compare

Today's Range: $6.50
▼
$6.96
50-Day Range: $6.24
▼
$14.96
52-Week Range: $6.05
▼
$27.27

Volume: 366,507 shs
Average Volume: 382,656 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $38.56

Institutional Ownership

Headlines

SEC Filings

Short Interest

About Trulieve Cannabis (OTCMKTS:TCNNF) Stock

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded on September 17, 1940 and is headquartered in Quincy, FL.

Receive TCNNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

TCNNF Stock News Headlines

January 20, 2023 | benzinga.com

Ricky Williams' Highsman Cannabis Products Launch In Arizona Via Trulieve

January 13, 2023 | msn.com

Jay-Z and TPCO Restructure Partnership: This Week in Cannabis Investing

February 2, 2023 | Investing Trends (Ad)

Solar Industry at Start of Long Bull Run?

The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.

January 13, 2023 | benzinga.com

Key Marijuana Executive Changes You Should Know About: This Company Got A New CEO & More News

January 12, 2023 | msn.com

Recreational Cannabis Coming To West Virginia As Dems Unveil New Bill

January 12, 2023 | markets.businessinsider.com

These Marijuana Companies Will Benefit From Connecticut's New Market Projected To Hit $300M In 2023

January 9, 2023 | seekingalpha.com

Cannabis Is A Long-Term Play (Podcast Transcript)

January 5, 2023 | msn.com

3 Chilling Headwinds Coming for Cannabis Stocks in 2023

February 2, 2023 | Investing Trends (Ad)

Solar Industry at Start of Long Bull Run?

January 5, 2023 | finance.yahoo.com

Trulieve Announces January 2023 Event Participation

January 3, 2023 | msn.com

Marijuana Stock Movers For January 3, 2023

December 28, 2022 | seekingalpha.com

Innovative Industrial: Cannabis Market At Risk To Worsening Macroeconomics

December 27, 2022 | msn.com

Trulieve Closes $18.9M Financing

December 27, 2022 | seekingalpha.com

Investing In The New Cannabis World After A Terrible 2022

December 22, 2022 | markets.businessinsider.com

Theraleaf Cannabis Dispensary Fined $50K For Pesticide Violations As Rash Of Weed-Related Lawsuits Continue

December 22, 2022 | finance.yahoo.com

Trulieve Announces Closing of $18.9 Million Financing

December 22, 2022 | benzinga.com

Trulieve Secures $71.5M Financing

December 22, 2022 | benzinga.com

Trulieve Settles With Occupational Safety And Health Administration

December 21, 2022 | finance.yahoo.com

Trulieve Announces Closing of $71.5 Million Financing

December 21, 2022 | benzinga.com

Layoffs In Cannabis Industry Continue: LeafLink Is Latest To Join Curaleaf, Weedmaps And Trulieve

December 20, 2022 | msn.com

Marijuana Stock Movers For December 20, 2022

December 16, 2022 | benzinga.com

Trulieve Cannabis's Return on Invested Capital Insights

December 13, 2022 | msn.com

Bearish Tuesday For Marijuana Stocks - Cipher Pharmaceuticals, iAnthus Capital Hldgs Among Top Gainers

December 13, 2022 | seekingalpha.com

Top Cannabis Pick For 2023: NewLake Capital Yields 9% With Double-Digit Growth

December 12, 2022 | msn.com

Cannabis Stock Gainers And Losers From December 12, 2022

December 12, 2022 | msn.com

Trulieve Sued In Federal Class Action Suit For Firing Workers 'Without Cause' And No Advance Notice

December 9, 2022 | msn.com

Lawmakers Delay SAFE Banking Act: This Week in Cannabis Investing

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TCNNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

TCNNF Company Calendar

Last Earnings: 11/15/2021
Today: 2/02/2023
Next Earnings (Estimated): 3/28/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:TCNNF
CUSIP: N/A
CIK: 1754195
Web: www.trulieve.com
Phone: (850) 480-7955
Fax: N/A
Employees: 6,900
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $38.56
High Stock Price Forecast: $51.00
Low Stock Price Forecast: $18.00
Forecasted Upside/Downside: +471.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Kim Rivers
Chairman & Chief Executive Officer

Steven M. White
President

Alex D’Amico
Chief Financial Officer

Jason Pernell
Chief Information Officer

Nilyum Jhala
Chief Technology Officer

Key Competitors

View All Competitors

TCNNF Stock - Frequently Asked Questions

Should I buy or sell Trulieve Cannabis stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TCNNF shares.
View TCNNF analyst ratings or view top-rated stocks.
What is Trulieve Cannabis' stock price forecast for 2023?: 4 equities research analysts have issued 1 year price objectives for Trulieve Cannabis' shares. Their TCNNF share price forecasts range from $18.00 to $51.00. On average, they predict the company's stock price to reach $38.56 in the next twelve months. This suggests a possible upside of 471.6% from the stock's current price.
View analysts price targets for TCNNF or view top-rated stocks among Wall Street analysts.
How have TCNNF shares performed in 2023?: Trulieve Cannabis' stock was trading at $7.57 on January 1st, 2023. Since then, TCNNF stock has decreased by 10.9% and is now trading at $6.7460.
View the best growth stocks for 2023 here.
Are investors shorting Trulieve Cannabis?: Trulieve Cannabis saw a increase in short interest during the month of December. As of December 30th, there was short interest totaling 671,200 shares, an increase of 68.5% from the December 15th total of 398,400 shares. Based on an average trading volume of 1,660,200 shares, the days-to-cover ratio is currently 0.4 days.
View Trulieve Cannabis' Short Interest.
When is Trulieve Cannabis' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our TCNNF earnings forecast.

How were Trulieve Cannabis' earnings last quarter?: Trulieve Cannabis Corp. (OTCMKTS:TCNNF) released its earnings results on Monday, November, 15th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by $0.13.
What guidance has Trulieve Cannabis issued on next quarter's earnings?: Trulieve Cannabis updated its FY 2022 earnings guidance on Friday, December, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.25 billion-$1.25 billion, compared to the consensus revenue estimate of $1.26 billion.
What is Trulieve Cannabis' stock symbol?: Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."
How do I buy shares of Trulieve Cannabis?: Shares of TCNNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Trulieve Cannabis' stock price today?: One share of TCNNF stock can currently be purchased for approximately $6.75.
How many employees does Trulieve Cannabis have?: The company employs 6,900 workers across the globe.
How can I contact Trulieve Cannabis?: Trulieve Cannabis' mailing address is 6749 Ben Bostic Road, Quincy, FL 32351. The official website for the company is www.trulieve.com. The company can be reached via phone at (850) 480-7955.

This page (OTCMKTS:TCNNF) was last updated on 2/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial